Synthesis and evaluation of tetrahydroindazole derivatives as sigma-2 receptor ligands

被引:14
作者
Wu, Zong-Wen [1 ]
Song, Shu-Yong [1 ]
Li, Li [1 ]
Lu, He-Lin [1 ]
Lieberman, Brian [2 ]
Huang, Yun-Sheng [1 ]
Mach, Robert H. [2 ]
机构
[1] Guangdong Med Coll, Sch Pharm, Dongguan 523808, Guangdong, Peoples R China
[2] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
关键词
Sigma receptor; Synthesis; Ligands; Tetrahydroindazole; Affinity; CELL-PROLIFERATION; BINDING-SITE; AFFINITY; ANALOGS; PROTEIN; PGRMC1; POTENT; SERIES; IDENTIFICATION; EXPRESSION;
D O I
10.1016/j.bmc.2015.02.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of tetrahydroindazole derivatives were synthesized and evaluated for their affinities for both sigma-1 and sigma-2 receptors. These compounds are hybrid structures of a tetrahydroindazole substituted benzamide and a 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety or a 9-azabicyclo[3.3.1]nonan-3-yl-amine moiety. These newly synthesized hybrid analogs showed various affinities for sigma-2 receptor without any significant affinities for sigma-1 receptor. In particular, compounds 12, 15b, 15c, and 15d, demonstrated moderate affinity and excellent selectivity for sigma-2 receptor. It is interesting to note that 3-5 carbon units between the tetrahydroindazole substituted benzamide and the 6,7-dimethoxy1,2,3,4-tetrahydroisoquinoline moiety are appropriate for sigma-2 receptor binding. No substitution on the 9-aza nitrogen is proper for sigma-2 affinity in the 2-(9-azabicyclo[3.3.1] nonan-3-yl-amino)-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl) benzamide analogs. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1463 / 1471
页数:9
相关论文
共 52 条
  • [1] Abate Carmen, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P246
  • [2] Trimethyl-4-oxo-4,5,6,7-tetrahydroindazole-1-acetic Acid: A New Lead Compound with Selective COX-2 Inhibitory Activity
    Abdel-Rahman, Hamdy M.
    Ozadali, Keriman
    [J]. ARCHIV DER PHARMAZIE, 2012, 345 (11) : 878 - 883
  • [3] Ablordeppey S. Y., 2008, BIOORGAN MED CHEM, V8, P2105
  • [4] A CoMFA investigation of sigma receptor binding affinity: Reexamination of a spurious sigma ligand
    Ablordeppey, SY
    El-Ashmawy, M
    Fischer, JB
    Glennon, RA
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (7-8) : 625 - 633
  • [5] Probing the proposed phenyl-A region of the sigma-1 receptor
    Ablordeppey, SY
    Fischer, JB
    Law, H
    Glennon, RA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (08) : 2759 - 2765
  • [6] Pgrmc1 (Progesterone Receptor Membrane Component 1) Associates with Epidermal Growth Factor Receptor and Regulates Erlotinib Sensitivity
    Ahmed, Ikhlas S.
    Rohe, Hannah J.
    Twist, Katherine E.
    Craven, Rolf J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (32) : 24775 - 24782
  • [7] Progesterone Receptor Membrane Component 1 (Pgrmc1): A Heme-1 Domain Protein That Promotes Tumorigenesis and Is Inhibited by a Small Molecule
    Ahmed, Ikhlas S.
    Rohe, Hannah J.
    Twist, Katherine E.
    Mattingly, Marlene N.
    Craven, Rolf J.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (02) : 564 - 573
  • [8] S2RPgrmc1: the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling
    Ahmed, Ikhlas S. A.
    Chamberlain, Cora
    Craven, Rolf J.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (03) : 361 - 370
  • [9] Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells
    Al-Nabulsi, I
    Mach, RH
    Wang, LM
    Wallen, CA
    Keng, PC
    Sten, K
    Childers, SR
    Wheeler, KT
    [J]. BRITISH JOURNAL OF CANCER, 1999, 81 (06) : 925 - 933
  • [10] Sigma receptors and cancer: Possible involvement of ion channels
    Aydar, E
    Palmer, CP
    Djamgoz, MBA
    [J]. CANCER RESEARCH, 2004, 64 (15) : 5029 - 5035